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Background: Around 30% to 62% of older individuals fall each year, with adverse consequences of falls being by
no means limited to physical injury and escalating levels of dependence. Many older individuals suffer from a
variety of adverse psychosocial difficulties related to falling including fear, anxiety, loss of confidence and
subsequent increasing activity avoidance, social isolation and frailty. Such ‘fear of falling’ is common and disabling,
but definitive studies examining the effective management of the syndrome are lacking. Cognitive behavioural
therapy has been trialed with some success in a group setting, but there is no adequately powered randomised
controlled study of an individually based cognitive behavioural therapy intervention, and none using non-mental
health professionals to deliver the intervention.
Methods/Design: We are conducting a two-phase study examining the role of individual cognitive behavioural
therapy delivered by healthcare assistants in improving fear of falling in older adults. In Phase I, the intervention
was developed and taught to healthcare assistants, while Phase II is the pragmatic randomised controlled study
examining the efficacy of the intervention in improving fear of falling in community-dwelling elders attending falls
services. A qualitative process evaluation study informed by Normalization Process Theory is being conducted
throughout to examine the potential promoters and inhibitors of introducing such an intervention into routine
clinical practice, while a health economic sub-study running alongside the trial is examining the costs and benefits
of such an approach to the wider health economy.
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Falls are common, frequently devastating events for older
people, with between 30% and 62% of older individuals
falling per year [1,2]. Falls are responsible for considerable
morbidity and mortality, with around 10% of falls resulting
in fractures [1]. The cost of falls to the UK economy is
estimated at £981 million [3], with more recent data
showing that 0.07% to 0.20% of the gross domestic prod-
uct and 0.85% to 1.5% of total healthcare expenditure in
western economies was accounted for by falls and their
consequences [4]. Adverse consequences of falls are by
no means limited to physical injury and escalating levels
of dependence. Many older individuals, both fallers and
non-fallers, experience a variety of adverse psychosocial
difficulties related to falling [5-15] including fear, anx-
iety, loss of confidence, and impaired self-efficacy (the
self-perception of ability to perform within a particular
domain of activities) [9,12] resulting in activity avoidance,
social isolation and increasing frailty [5-15]. The umbrella
term for these problems is ‘fear of falling’, a common
and disabling problem in older individuals, found in be-
tween 3% and 85% of community-dwelling elders who fall,
and up to 50% of those who have never fallen [7-9,15].
The optimal management strategy for fear of falling and
its adverse physical and psychosocial sequelae is poorly
understood. Much previous research has focused on phys-
ical treatments including home- and community-based
exercise interventions, tai chi and multifactorial inter-
ventions aimed at reducing fall rates, with fear of fall-
ing reported as a secondary outcome in the majority of
these studies [7]. A recent systematic review found 12
high-quality randomised controlled trials (RCTs) reporting
effects on fear of falling in such studies, but only one
primarily aimed at reducing fear of falling [15]. The in-
terventions were conducted across a variety of settings,
but home-based exercise, community tai chi and home-
based multifactorial interventions all improved fear of
falling [7], though a recent geriatric outpatient-based
multifactorial intervention study found no such bene-
fit [16].
While such physical interventions may be of benefit in
selected populations, the profile of the disorder and its
psychosocial complications suggest that well-designed
psychological interventions may help ameliorate fear of
falling more definitively. Several studies have examined
an explicitly cognitive behavioural therapeutic (CBT) ap-
proach in fear of falling in community-dwelling elders,
or used CBT techniques as part of a wider intervention
strategy. Tennstedt et al.’s Matter of Balance study assessed
the ability of an eight-session, 4-week group CBT with
exercise instruction to improve fear of falling and re-
lated activity restriction [17]. Significant differences be-
tween intervention and control groups were seen in fear
of falling as measured by the Falls Efficacy Scale (FES) [12]and activity during follow-up. The magnitude of improve-
ment in FES scores attenuated over time, prompting the
authors to suggest a booster session should be used in fu-
ture studies and in clinical practice [17]. Clemson et al.
similarly used what they described as a ‘small-group
learning environment’ (though in practice, some of the
methods used included CBTs) of 12 individuals per group
for 2 hours per session over 7 weeks to improve self-
efficacy and reduce falls [18]. The intervention incorpo-
rated a variety of learning strategies to facilitate behaviour
change, including education regarding exercises to im-
prove falls risks, medication and home environmental re-
view and medication management [18]. There was a 31%
reduction in falls (relative risk 0.69, 95% CI 0.50 to 0.96,
P = 0.025) in the intervention group, though interest-
ingly there was no corresponding change in FES scores
[18]. More recently, Zijlstra and colleagues conducted a
RCT of a multicomponent cognitive behavioural group
intervention in older community-dwelling elders [19]. Five
hundred and forty participants were drawn from a ran-
dom sample of 7,431 individuals who reported (through
self-report questionnaires) ‘at least some fear of falling’,
though the precise method of assessment was not speci-
fied. Following randomisation, the intervention group
underwent a structured 2-hour group CBT intervention
based on the investigators’ previous work once weekly for
8 weeks, with booster sessions 6 months following the last
session. A primary outcome was not specified, and while a
power calculation was supplied based on a ‘difference of
2.5 points’, the authors fail to specify on which scale. The
beginning of the trial predates widespread use of the FES-
International version (FES-I) [20] (later advocated by
the same group as the most appropriate measure for
such studies [7]), instead using a single item question
on fear of falling as well as an unspecified scale, likely
to be the original FES from the description and reference
supplied [19]. Other outcomes included perceived control
over falling and daily activity as well as falls. There were
no measures of physical function despite the prior evi-
dence base suggesting improvement in fear of falling with
the exercise-related measures as described above. All out-
comes showed significant differences between control and
intervention groups at 2 and 8 months follow-up, with
between-group differences persisting at 14 months in fear
of falling and perceived control over falling but not in
the other outcome measures. There was a 30% attri-
tion rate in the intervention group and 19.6% attrition
rate in the control group [19]. The study intervention
was carefully developed and grounded in CBT, but in-
terpretation and application is hampered considerably by
the lack of clarity on sample size calculation and outcome
measures and the absence of generic quality-of-life mea-
sures and measures of physical functioning. Importantly,
there is also no health economic analysis [19] to guide
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context because of the size of the clinical problem.
Fear of falling is thus a common, disabling and debili-
tating condition in older adults but the current under-
standing of its management is limited. There is a small
evidence base to support the use of some physical ther-
apies to improve the syndrome, and promising early data
from a few studies supporting the use of psychological
therapies, in particular CBT. The cognitive behavioural
model [21] of a problem situation being maintained by an
interaction between physiological, behavioural, cognitive
and affective responses is paradigmatic for fear of falling,
and offers the hope of a viable therapeutic option. Previ-
ous studies are hampered by the factors already described,
while the issue of the economic viability of such a treat-
ment has yet to be explored.
There is a need for many more trained cognitive be-
havioural therapists than are currently available; the de-
velopment of a cognitive therapeutic package for the
management of fear of falling that can be delivered rou-
tinely by non-specialist staff such as healthcare assistants
(HCA) is vital if this common and debilitating condition
is to be tackled effectively. CBTcan be delivered by suitably
trained non-psychotherapist staff [22,23], but to the best of
our knowledge, this approach has not been attempted in a
RCT in this context previously. In addition, only group in-
terventions have been studied so far, with therapy deliv-
ered on a one-to-one basis yet to be tested in a fear of
falling cognitive behavioural intervention study.
Understanding the dynamics of developing, delivering
and trialling a novel intervention as a process is useful
because it will contribute to understanding the profes-
sional and organisational factors that promote or inhibit
adherence to treatment protocols and intervention deliv-
ery; and how practical and methodological problems are
defined, understood and resolved by the project team in
the course of the study. The need for understanding the
dynamics of complex interventions [24], and undertaking
process evaluation is now well understood [25]. Such work
is important to underpin the transportability, workabil-
ity, and integration of interventions into routine clin-
ical practice. In the case of this trial, our aim is to collect
longitudinal ethnographic data that will help us to under-
stand the social processes and relationships that lead the
intervention and trial to take a particular shape and direc-
tion. In earlier studies of trials and other interventions,
May and Finch developed a robust explanatory model of
normalization processes [26] that defines psychological
and sociological mechanisms of behaviour and action that
have been empirically demonstrated to be important in
the implementation of complex interventions, and that
have been revealed by evaluation in randomised controlled
clinical trials. This approach is vital for the understanding
and more widespread adoption of such an intervention.In summary, we aim to develop a cognitive behaviour-
based intervention to be delivered by HCAs on a one-
to-one basis to community-dwelling older individuals
attending falls services with an excessive or undue fear of
falling and then to conduct a randomised controlled study
of this intervention plus usual multidisciplinary care ver-
sus usual multidisciplinary care alone. Our study, incorp-
orating a qualitative process evaluation and economic
evaluation alongside a patient RCT, will answer defini-
tively the question of whether an enhanced intervention
to reduce the fear of falling for community-living older
people would be effective and cost effective in reducing
anxiety through its rigorous design and carefully chosen
primary and secondary outcome measures, while assessing
the cost and outcomes of such an intervention.
Methods
The study is divided into two distinct phases, the first de-
veloping the novel cognitive behavioural therapy-based
intervention (CBTI) and the second the RCT assessing the
effectiveness of the intervention in reducing fear of falling.
Qualitative and health economic studies straddle the two
phases (Figure 1).
Phase 1
Pilot study developing a cognitive behavioural model tai-
lored to older patients [27] with fear of falling, based on
the Medical Research Council (MRC) model of complex
intervention development [28] and incorporating elements
of previously successful CBT-based interventions [16-19].
Patients with significant fear of falling attending our com-
munity falls service were included in this phase of the
study, and HCAs trained to deliver the intervention.
Phase 2
Parallel-group patient RCT of the novel CBTI plus usual
multidisciplinary care versus usual multidisciplinary care
alone in patients with significant fear of falling attending
multidisciplinary falls services. Patients are randomised in
a 1:1 ratio, using a web-based system to ensure conceal-
ment of allocation, to intervention and control groups.
Randomisation is stratified by gender (to avoid any poten-
tial sex differences in the response of older individuals to
CBT-type interventions) and by whether the patient has
been referred for strength and balance training. Study
centre (random effect) and pain score (fixed effect) are
also entered in to the randomisation system as stratifica-
tion variables. Fear of falling is well documented in fallers
from 40 years to extreme old age [6-10]; accordingly, we
do not feel that stratification by age will add to the assess-
ment of the intervention’s effectiveness; in addition, we
can find no compelling evidence that older individuals re-
spond to CBT differently. Our study is an individually ran-
domised trial, delivered by three therapists (HCAs), and as
Consort ﬂow diagram illustrang STRIDE Study
Community-dwelling patients ≥60 years 
presenting to falls services
832 patients with FES-I score >23
Excluded/declined 30% (n=250)
Follow-up 12 months
(n=154)
CBTI plus usual falls service care
(n=206)
Follow-up 12 months
(n= 154)
Usual falls service care 
(n=206)
Allocation
Follow-Up
Enrollment
(12 months)
412 Randomized
Initial evaluation for fear of falling
Phase 1
CBTI development (20-30 patients) and staff training in 
implementation (10 months)
Phase 2
Further evaluation for fear of falling and RCT
Process and normalisation 
qualitative study and economic 
evaluation
Attrition (mortality, 
lost to follow-up): 
25% (n=108)
Figure 1 Consort flow diagram illustrating the STRIDE study.
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(that is patients allocated to the control condition receiv-
ing CBTI). We believe that this risk is minimal, particu-
larly at clinician level as the HCAs delivering the CBTI
during Phase 2 will only be seeing the intervention group
of patients and will not be part of the teams delivering
usual care.
Across project duration
A qualitative process evaluation will be conducted across
the duration of the study, in parallel to the Phase 1 and
Phase 2 activities. Data collection will involve a variety of
ethnographic methods, including semi-structured inter-
views, observations and documentary analysis. Participantswill include health professionals and patients as well as
members of the trial team.
Planned interventions
Phase 1: CBTI development methodology
The MRC revised their framework for the development
of complex interventions [28], acknowledging that the
process of development is circular and iterative, but that
there are still distinct, if overlapping, stages that can be
used to structure the intervention development process.
The starting phase should be the establishment of the
theoretical and empirical grounds of the intervention.
This should involve a review of the extant evidence base
and an identification or development of the theory on
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mend a modelling phase in which the nature of the
intervention is specified. The key tasks of this stage are
to identify the target problem, in our case fear of falling,
the mechanisms whereby the proposed intervention will
lead to change, and a specification of how this change
will be measured. There is currently less consensus on
how this part of the process should be enacted, but there
is an agreement that the process of intervention devel-
opment and implementation should be well documented
enough to be independently replicable. The intervention
should then be further refined and re-evaluated to en-
sure its effectiveness. The objectives for development of
the CBTI were therefore:
1. To further review the evidence base for fear of
falling.
2. To investigate patients’ experience of fear of falling
using a cognitive behavioural model as an
assessment framework in a series of patient
interviews.
3. To use data gathered in these first two stages to
model a theoretically structured and empirically
grounded intervention for this condition, including
explicit formulation of therapeutic targets, change
processes and outcome evaluation.
4. To interview patients and clinic staff to explore the
acceptability of the proposed intervention and to
adapt the intervention accordingly.
5. To use the data from steps 3 and 4 to further
develop and formalise the components of a short
CBT training package for the intervention delivery
staff.
6. To produce clinician and patient treatment manuals
for the CBTI and establish the form of the treatment
as usual arm, since this forms the control condition,
with the intervention comprising the CBTI plus
treatment as usual.
Identification of existing theory and evidence base
From the existing literature (see ‘Background’ above) we
already have some indications of falls and fear of falling
epidemiology and patient characteristics, possible mecha-
nisms involved in the predisposition to and maintenance
of fear of falling, trials of psychosocial interventions in this
condition and current service provision to this population.
It is abundantly clear that fear of falling is a significant
clinical problem, and those patients who experience it are
also frequently anxious, depressed and activity avoidant.
Patient interviews for CBTI development
The perspectives of patients are important for interven-
tion development, in terms of understanding both (i) the
appropriateness of the intervention for managing theclinical problem, and (ii) social and organisational factors
that are likely to affect the patient’s uptake and involve-
ment in the intervention. This part of the intervention
development programme sought to further investigate
patient characteristics, with a view to model develop-
ment, by interviewing approximately 20 patients using
a broad cognitive behavioural framework as an assess-
ment tool. The cognitive behavioural model distin-
guishes between what made a person vulnerable to a
problem (predisposing factors), what triggered the current
problem (precipitating factors) and what is currently
maintaining it (perpetuating factors). The model further
distinguishes between physical, emotional, cognitive,
behavioural and social factors in each domain. Finally,
it looks for interactions between perpetuating factors
(such as how anxious thoughts may increase physio-
logical arousal, and vice versa). Such an approach resonates
with Zijlstra and colleagues recent cognitive behavioural
intervention aimed at improving the perception of falls
and falls risks and increasing activity and safe behaviour
[19]. Using this model as a template, we further investi-
gated the relevant factors in the cause and maintenance of
fear of falling.
Also in this CBTI developmental phase, and as part of
the qualitative process evaluation, a set of 10 interviews
were conducted with a different sample of patients, to
focus explicitly on social and organisational factors likely
to affect normalisation of the intervention from the per-
spective of patients.
CBTI model development
Data from the literature and interviews described were
used to further refine the extant models of fear of falling.
On the basis of current knowledge [16-19], we would
expect anxious cognitions to be maintaining activity
avoidance; physical tension and anxious cognitions to be
interfering with walking; underactivity to be maintaining
physical weakness and loss of confidence and/or compe-
tence. Interventions were developed accordingly, target-
ing these maintaining factors or whatever else emerged
from the preceding stages.
Interviews with staff
As noted above, most of the literature cited notes the
need for, and lack of, psychological service provision in
this area. With a view to making our intervention as prag-
matic and widely replicable as possible, we trained HCAs
in the model and interventions derived from the outlined
research. As previously noted [25,26,29] this is a complex
process with many potential barriers and facilitators at the
individual, interpersonal and institutional level. To maxi-
mise the possibility of the intervention’s uptake we utilised
May’s Normalisation Process Theory [26,30]. This pro-
vides a framework for assessing the likelihood of a new
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the process whereby it does so. During Phase 1, the quali-
tative process evaluation included a set of semi-structured
interviews with key professionals involved in the develop-
ment and delivery of the intervention (n = 5-7). This
included clinical and other related professionals and pro-
vided us with a framework for predicting and increasing
the likelihood of the intervention’s implementation.
Putting the training and trial materials together
Our team has experience of training and supervising
non-mental health professionals in psychosocial inter-
ventions [23] and has already evolved materials and
methods, which were further refined for this staff and
patient group. These materials are now being trialled in
the randomised trial, as detailed below.
Phase 2: RCT of CBTI versus usual care
Patients are recruited in the falls clinics following appro-
priate identification of inclusion and exclusion criteria.
They are then given study literature and an expression
of interest form for return by post. A recruitment visit is
then arranged, and informed written consent obtained.
Patients are randomised in 1:1 ratio, with stratification
by gender and referral to strength and balance train-
ing classes to CBTI plus treatment as usual, or control
(treatment as usual) groups. CBTI sessions last approxi-
mately 45 minutes with 15 minutes of preparation time,
and are based on an individualised formulation that iden-
tifies and targets the factors maintaining fear of falling for
that individual. Treatment is weekly for 8 weeks, with a
single reinforcement CBTI session 6 months after the last
CBTI session. Follow-up will be for 12 months to assess
the longevity of CBTI’s effects. Treatment as usual com-
prises the routine care that all patients at the falls clinic
receive. All undergo detailed falls-oriented physiotherapy
assessment, lying and standing blood pressure measure-
ment, electrocardiography, bone health assessment using
the FRAX™ [31] tool, Mini-Mental State Examination
(MMSE) [32], 15-item Geriatric Depression Scale [33],
FES-I [19] and visual acuity assessment [1]. A comprehen-
sive overview with a falls expert, utilising the information
gained from the other parts of the evaluation, rounds off
the assessment.
Inclusion/exclusion criteria
Inclusions
Consecutive community-dwelling patients aged 60 years
and over, of both sexes, attending falls services in the
North East of England with excessive or undue fear of
falling as assessed by a FES-I score of >23. The original
FES [12] and its internationally validated derivative scale
the FES-I [20] were not designed as scales with ri-
gidly defined numerical cut-off values, rather as toolsto explore different aspects of falls and balance confi-
dence in individual patients through the medium of
self-efficacy evaluation. Use of the scales as tools for
defining and quantifying fear of falling in the context
of inclusion criteria for fear of falling RCTs has thus
been controversial. Counterbalancing this is the FES-
I’s undoubted clinical and research validity and utility,
its validation in UK patient groups and its translation
in multiple languages and cultures, allowing potential
cross-cultural comparisons of data [7]. A number of stud-
ies have provided some useful data on cut-off scores to
define those likely to have significant fear of falling.
Ersoy et al. followed 125 women age 50 years and over
for 6 months, comparing confidence and fear of falling
measures in those who fell versus those who did not. An
FES-I score of >26 was a potent predictor of future falls in
those who fell (OR = 7.28, per additional point, 95% CI
2.25 to 23.61, P = 0.001) [34]. A much larger and more re-
cent longitudinal study showed that an FES-I score of >23
on the 16-item version used routinely in our clinic (and
in this study corresponded with high concern about fall-
ing) [35]. The authors, while sympathetic to the concerns
expressed above, reasonably argued that intervention re-
search in fear of falling was hampered by a dearth of re-
sponsive, valid and sensitive instruments and that their
approach allows such use of the FES-I [35]. Accordingly
we have chosen to use the cut-off of >23 for participant
inclusion in our study.
Exclusions
Patients with cognitive impairment (MMSE <24) are ex-
cluded from the study given the paucity of data on the use
of fear of falling measures in this patient group and the
difficulties in conducting CBTIs in those with significant
cognitive impairment. Patients with a life expectancy
of <1 year and those requiring psychosocial interventions
unrelated to fear of falling will also be excluded.
Ethical and regulatory arrangements
Favourable ethical opinion from the Newcastle and North
Tyneside 1 Research Ethics Committee (Phase 1 REC ref-
erence: 11/NE/0090 Phase 2 REC Reference: 12/NE/0006)
has been obtained and subsequent Research and Develop-
ment and Caldicott approvals have been granted to all
parts of the study. The Newcastle upon Tyne Hospitals
NHS Foundation Trust is the sponsor for the trial.
Risks and anticipated benefits for trial participants and
society
The potential risks associated with the STRIDE study are
few. The main anticipated issue centres on the potential
for patients to gain confidence and lose their fear of falling
in a way that is inconsistent with their improvement (or
lack thereof) in physical function. In other words, patients
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fear of falling have the potential to increase activity levels
through amelioration of the condition with the CBTI be-
fore any physical interventions have been able to take ef-
fect and therefore to increase their risk of an actual fall. In
practice, this is unlikely given the prolonged course of the
CBTI. We believe the potential benefits to individuals and
society in terms of increasing activity, avoidance of social
isolation, enhancement of independence and avoidance of
injuries and hospitalisations from examining the effective-
ness of psychological interventions in people with fear of
falling are, nevertheless, worth such risks.
Sample size
Phase 1
Anxiety disorder tends to have a fairly narrow range of
maintaining factors which, most usually, are catastrophic
beliefs and activity avoidance. The psychological con-
structs of fear of falling suggest that a similar range
of maintaining factors is likely to be in operation. We
therefore expected the number of patients needed to
consistently identify such factors to be relatively small;
prior work from our group showed that saturation was
reached with 12 [23], and will be no more than 30, inter-
views. Phase I was successfully completed with 15 such
interviews.
Phase 2
Primary outcome is change in fear of falling (as mea-
sured by the FES-I) at 12 months. The estimated stand-
ard deviation is 12.5 [20]; the difference in group means
that we wish to be able to detect is 4.0 (per clinical judg-
ment in combination with observed effects in a range of
studies) [18,35] corresponding to a standardized effect
size of 0.32. Accordingly, the number required to pro-
vide full outcome data (80% power, 5% significance level)
is 154 per group, or 308 in total. To allow for 25% drop-
out (from previous experience in falls studies run locally
with this patient group and from the CBT in fear of fall-
ing literature), we will recruit 412 subjects.
Qualitative process evaluation (running across Phases 1
and 2)
Participants in the process evaluation will include mem-
bers of the trial team (n = 10-15, each interviewed two to
three times during the project), professionals involved in
the delivery of the intervention (n = 5-7, interviewed at
multiple points during the study) and patients who would
be eligible for the CBTI (Phase 1 n = 10) and those receiv-
ing the intervention (Phase 2 n = 20).
Statistical analysis
The primary analysis will be based on fear of falling (FES-I)
assessed at baseline and 12 months. The change in fear offalling will be analysed using analysis of covariance. The
dependent variable will be the FES-I score at 12 months;
baseline FES-I will be included as a covariate. Stratifica-
tion variables (gender, referral to strength and balance
training classes) will be included as fixed effects. Potential
differences between therapists will be investigated by fit-
ting an additional random effect. Secondary outcomes will
be assessed using similar methods.
Effect of missing data
This is a comparatively frail population and we can ex-
pect some drop-out during the study. It is likely that
those participants who are lost to follow-up during the
trial may also be people with a tendency to experience
poorer quality of life (in terms of fear of falling) than
those who remain in the study. In this situation, the data
cannot be considered to be missing at random. On the
contrary, the event of a patient failing to complete the
study may be informative. It is necessary to take into
account any difference in drop-out rates and the non-
randomness of the drop-out when comparing fear of
falling per the FES-I between the two treatment groups.
This will be done by jointly modelling ‘survival in the
study’ and the repeated measures of fear of falling simul-
taneously [36] using software that has been developed as
part of an MRC-funded programme of work (Grant
G0400615; Statistical methodology for longitudinal stud-
ies in clinical research; Williamson PR, Diggle PJ and
Henderson R). Time to drop-out will be analysed using
a Cox proportion hazards model incorporating random
effects. Fear of falling will be modelled using mixed models
appropriate for repeated measures. A key feature of each
of these models is that within each of them it is possible to
fit a latent variable that can be conceptualised as the pa-
tient’s propensity to experience poor outcomes (both their
likelihood to drop out of the study and their likelihood
to have poorer FES-I scores). It is the inclusion of this
latent variable that allows us to adjust our estimates of the
treatment effect to allow for the different rates of drop-
out in each group. Both models are estimated simultan-
eously; parameter estimates are based on maximising the
joint likelihood over both the survival and repeated mea-
sures data.
Outcome measures
Primary outcome measure
Change in fear of falling as measured by the FES-I [20].
Secondary outcome measures
Falls a) Number of patients falling; b) number of falls; and
c) fractures and significant soft tissue injuries: the close re-
lationship between fear of falling and falls [5-20,37] means
that measurements of falls and their adverse conse-
quences are vital. Falls research is often hampered by
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outcome data. As per recent consensus guidelines [38],
falls will be defined as ‘an unexpected event in which the
participant comes to rest on the ground, floor, or lower
level’. Participants and carers will be given verbal and writ-
ten instructions to ‘. . . record each day in weekly-returned
postage paid falls diaries any fall including a slip or trip in
which you lost your balance and landed on the floor or
ground or lower level’; weekly telephone prompts will be
used to ensure contemporaneous reporting. We have pre-
viously used this technique successfully in similar popu-
lations, with published data showing in excess of 90%
return rates [39,40].
Domain-specific quality of life
Hospital Anxiety and Depression Scale (HADS): while
fear of falling is the primary outcome measure, the inter-
related nature of fear of falling and anxiety mean that
change in anxiety is clinically highly relevant. In addition,
it is vital to assess depression in this population [10]. The
HADS, though widely used, was originally validated in a
population with a maximum age of 65 years [41]. How-
ever, a recent large scale UK study in four centres across
England, Wales and Scotland has shown that the scale’s
psychometric constructs are intact and applicable to
community-dwelling older people [42].
Generic quality of life
World Health Organization Quality of Life questionnaire-
older adults module (WHOQOL-OLD) [43], EuroQol 5-
dimension scale (EQ-5D), the five-level version [44] and
Short Form six-dimension health survey (SF-6D) [45]:
the 24-item WHOQOL-OLD is a module of the World
Health Organization’s broad measure of quality of life,
the WHOQOL, which was designed for adults of all ages.
The WHOQOL-OLD includes additional items specific to
older people. The EQ-5D is a generic quality of life meas-
ure that has the added benefits of enabling cost utility ana-
lysis (below), as does the SF-6D.
Social participation and social isolation
Social Disconnectedness and Perceived Isolation Scales
[46,47]: avoidance of social contact and social isolation
are crucial co-factors both caused by, and contributing
to, fear of falling. Recent work from Cornwell et al. has
shown that the Social Disconnectedness and Perceived
Isolation scales [46,47], which measure both social isola-
tion and participation, may be particularly useful in
evaluating interventions in older people.
Impact on function
Short Physical Performance Battery (SPPB) [48-50], func-
tional reach [51], handgrip strength [52]: the SPPB is a well-
validated set of lower limb performance tests (measureswalking speed over the middle 8 feet of a 12-foot course
at the participant’s own ‘usual speed’, a series of chair
stands to assess muscle power, plus a test of balance),
which has already been used in major surveys such as
the Women’s Health and Aging [50]. Performed by one
trained person, the SPPB takes 10 to 15 minutes to
complete, with a composite score being derived by sum-
ming the category scores for each of the three tests. Func-
tional reach is a good indicator of confidence in balance
and increased risk of having a fall, while the measure-
ment of maximum isometric handgrip strength (using
a dynamometer) has functional relevance for supporting
weight (for example holding on to a stair rail). It has been
included in numerous surveys, and is predictive of both
disability and mortality.
Primary and secondary outcome measures are performed
by research assistants in the participants’ homes or at the
falls clinic.
Health economic evaluation
The economic evaluation will address the following crit-
ical resource allocation questions:
1. From the healthcare system perspective, what are
the incremental costs and outcomes (FES-I) of treatment
of usual falls service care that includes CBTI over usual
falls service care usual among patients with a heightened
fear of falling in the short term (12 months from the
start of treatment, from the trial)?
2. From a more societal perspective, what are the in-
cremental costs and quality-adjusted life years (QALYs)
of the treatment options among patients with a height-
ened fear of falling in the short term (12 months from
the start of treatment)?
The interpretation of the economic evaluation will cru-
cially depend upon the clinical outcome of the trial [53].
For each of 1 and 2, should the therapy result in improved
outcomes and cost savings relative to normal care, then
the therapy would, according to the economic evaluation,
be unambiguously recommended for adoption. Otherwise,
should the treatment result in both increased costs and
QALYs over normal care, the incremental cost per QALY
gained will be calculated, thus showing the rate of return
of QALYs gained for additional resources invested.
Stochastic sensitivity analysis will be undertaken to ex-
press the uncertainty around the incremental cost per
life year gained/QALY ratio based on mean costs and
outcomes [54-56]. An alternative way of looking at the
above issues, however, is to say that the trial has been
designed as a difference trial, and, therefore, we will at-
tempt to estimate incremental cost per QALY, focusing
on the joint density of costs and effects irrespective of
their precision [57]. Results will be presented in the form
of cost acceptability curves, thus using net benefit cri-
teria [58].
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1. Intervention and other outpatient expenditures: the
costs for providing the therapy will be estimated on a per
patient basis. This will be derived from the total costs of
providing the therapy. This will include the training time
for the falls service HCAs and any additional time and re-
sources required over the eight weeks when the therapy is
delivered, as well as the cost of initial evaluation for fear
of falling. Data about levels of activity will also be used to
inform sensitivity analyses.
2. Resource use outside of the falls service: trial partic-
ipants will be asked, during the follow-up 12-month inter-
views of RCT participants, about their use of primary
and secondary care and other community-based services.
Again, use of such services will be costed using local rates
of pay and prices. The interview schedule will also include
questions on private costs incurred by patients, including
over-the-counter expenses and the cost of accessing med-
ical care, such as travel expense and lost time from leisure
and work activities in those who are still economically ac-
tive. We also include questions about the amount of infor-
mal care provided by friends and family of people with a
heightened fear of falling. The cost of this care will be esti-
mated from equivalent professional care providers pay
when applicable and by the human capital approach [59].
To generate a cost per QALY, data on ‘utility’ or quality
of life are required in combination with data on survival.
Quality-of-life data will be gathered primarily using the
EQ-5D [60,61]. The EQ-5D is a generic, preference-based
measure of quality of life in which ‘health’ is defined in
terms of five broad dimensions. Patients will be asked to
rate their health status in terms of each of these dimensions
every six months (when visiting clinics for follow-up). In
the UK, health states in the EQ-5D classification have
been allocated scores derived from a survey of values by
members of the general public (where 0 = death and 1 =
full health) [62]. The SF-6D will also be used to translate
outcomes measured by the SF-36 into health state utilities
using of a recently produced ‘tariff ’ [45]. The requisite
self-response items for these quality-of-life measures will
be gained through self-completion questionnaires unless
the patient requires support in which case they are inter-
viewer administered during routine visits. In the case of
failure to return, these data are collected by telephone
interview. As quality-of-life data are not collected on a
continuous basis, power curves (simply, a form of extrapo-
lation) can be fitted to model quality-of-life profiles for the
interventions groups from baseline to end of follow-up
[45]. These power curves will take account of differences
in survival between the groups, so permitting generation of
a QALY for each mode of care and, more importantly, a
QALY difference between them.
In addition to the above, we propose to better estimate
the effect on quality of life of a fear of falling. Followingvalidation of the scale by factor analysis [63] to ensure
that it adequately represents concerns about falling during
social and physical activities, we will estimate the effect on
quality of life of a fear of falling. We will do this by explor-
ing the degree to which any discrepancy between EQ-5D
tariff values and self-reported quality of life are explained
by a fear of falling. Should the FES-I be unsuitable, we will
attempt to estimate the effect of a fear of falling directly
from patients by means of a standard gamble or similar
preference elicitation method.
Qualitative process evaluation of the trial
The purpose of the process evaluation is to understand
the organizing processes that underpin delivery of the
trial and its reception by professionals and patients, we
will undertake an ethnographic sub-study within the trial.
May and colleagues have employed these methods previ-
ously [64-66]. The aim of the study is therefore to identify,
describe, and explain the professional and organizational
factors that promote or inhibit the implementation and
integration of the intervention.
Throughout the study we will track the activities of
key personnel and their interactions with each other as
the trial develops. We will examine the implementation
of the intervention by a rolling programme of interviews
with members of the trial team (maximum n = 15), along
with observations of team and other relevant meetings
(n = 9 approximately), that focus on the delivery and take
up of the intervention by participating health professionals
and service users. We will interview all professionals in-
volved in intervention development and service delivery
(n = 7 approximately) including clinical and related profes-
sionals who will be able to contribute different perspec-
tives. Professionals will be interviewed at multiple time
points across the duration of the study, but we will utilise
brief follow-up telephone interviews of these individuals
to explore how the evaluation and interpretations of the
intervention changes over time without overburdening in-
dividuals. The range, flexibility and depth of ethnographic
research is a significant advantage in such work, and rep-
resents the only way such a project could be undertaken.
We will interview a purposive sample of patients (n = 10
during Phase 1; n = 20 during Phase 2) focusing on their
views/experiences of the intervention and factors affecting
normalisation from their perspective. In all cases, inter-
views and observations will be undertaken only when
informed consent has been obtained and recorded from
participating researchers, patients, and health professionals.
To reduce the burden of research, interviews with partici-
pating patients will not exceed 45 minutes duration with-
out their express permission. All interviews will take place
at a time and location of the interviewee’s choosing. Meet-
ings and interviews will be audio recorded using digital
voice recorders. Audio recordings will be transcribed,
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(with particular attention to removing identifying data
from professionals’ transcripts). Transcripts will be
stored in password-protected computer systems, and
non-anonymised voice recordings or transcripts will
be handled only by members of the research team and
transcribers who have signed appropriate confidentiality
agreements. We will use Normalization Process Theory as
a conceptual framework from which to develop a struc-
tured qualitative analysis of the transcript data set using
the Framework method pioneered by Ritchie and Spencer
[67]. This analysis will lead to a robust conceptual model
of the factors that have affected the course of the interven-
tion. This model will be of value to other clinicians and re-
searchers wishing to deploy the intervention since it will
provide a guide to implementation, embedding, and inte-
gration in everyday clinical practice.
Outcome data collection
Primary and secondary outcomes will be measured at
baseline (pre-randomisation), at 8 weeks (that is at the
end of CBTI) and 6 and 12 months post-randomisation.
Assessment will also be made of harms, level of social care
and dependency. Weekly symptom diaries (validated in
similar populations [39,68]), completed and submitted
weekly for 12 months, will record falls and injuries as de-
scribed previously. Data will be collected for the purpose
of the process evaluation on an ongoing basis over the
course of the project.
Research governance
Sponsor
Newcastle Hospitals NHS Foundation Trust is the trial
sponsor and the study was adopted by the Northumberland,
Tyne and Wear Comprehensive Local Research Network.
Trial steering committee (TSC)
A trial steering committee comprising an independent
topic area expert (Professor J Mason, Durham University)
to act as chair of this important committee. Along with
SWP (chief investigator (CI)), the study statistician (NS)
and trial manager (CM), we also invited an independent
falls expert (Dr C Bailey, Northumbria University), an in-
dependent medical statistician (Dr C Ramsay, Aberdeen
University) and lay representative (Mrs A Watt, Age UK
North Tyneside). Observers from the National Institute of
Health Research Health Technology Assessment (NIHR
HTA) programme (the funding body) are invited to all
TSC meetings.
Data monitoring and ethics committee (DMEC)
An independent chair (Professor RA Kenny, Dublin) leads
the DMEC, with other members including an experienced
trial statistician (Dr S Lewis), and a clinician with aninterest in falling (Professor D Skelton, Glasgow Caledonian
University) who are not part of the trial. The DMEC
reports to the TSC and (via the TSC) to the HTA
programme. Adverse events amongst study participants
are collected and classified with respect to serious-
ness, causality and expectedness; the assessment of ad-
verse events is made in the by the CI, and ultimately to
the clinical members of the DMEC.Project timetable
Study start date: 1 June 2011
Phase 1: 10 months, to 31 March.2012
Phase 2: Participant recruitment: to 28 February 2014,
final follow-up 31 January 2015.
Data analysis and write up: 3 months.
End of study: 30 April 2015.
Process evaluation data collection and analysis are
conducted as appropriate at key stages throughout
Phases 1 and 2 of the project.Discussion and trial status
Phase I of the study was completed successfully, with
the development of training materials and successful re-
cruitment and training of the HCAs in delivering the
CBTI to time and target. Despite pre-study qualitative
work suggesting an appropriate timetable for recruit-
ment, Phase II began to run into recruitment problems
from an early stage. A recovery plan was put in place
following qualitative interviews with potential study par-
ticipants, actual participants, carers and staff members
to identify barriers and promoters of recruitment. With
the assistance of the TSC and agreement with the DMEC
and the funder, NIHR HTA, alongside appropriate permis-
sions and approvals, two further sites to the original single
study site were brought on board. A 7-month extension
to the study was granted, with the desired outcome of
the appropriate recruitment target within reach at time of
writing.
The CBTI has uncovered interesting insights into fear
of falling that will be of use to researchers trying to im-
prove this nebulous and limiting condition regardless of
the outcome of the RCT. The use of non-mental health
practitioners in this role has been studied previously
with our experience in this study reinforcing the poten-
tial for suitably trained and supervised HCA assistant
grade staff to perform such therapies. This has clear im-
plications for cash-strapped health providers with a rela-
tively small base of clinical psychologists and therapists
available to manage such ubiquitous clinical problems.
Similarly, the process evaluation has already yielded im-
portant observations that will be of use to researchers
and those implementing healthcare innovations.
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